Back
Heron Therapeutics Stock Price Chart
Sponsored
HRTX
Sponsored
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
21
HRTX
Heron Therapeutics
Last Price:
2.00
Seasonality Move:
-8.85%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More- The current trend is relatively stagnant and HRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Heron Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.98 | Buy |
20-day SMA: | 1.89 | Buy |
50-day SMA: | 2.22 | Sell |
200-day SMA: | 2.6 | Sell |
8-day EMA: | 1.96 | Buy |
20-day EMA: | 1.96 | Buy |
50-day EMA: | 2.2 | Sell |
200-day EMA: | 2.45 | Sell |
Heron Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 53 | Buy |
Chaikin Money Flow: | 1229868 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 1.99) | Buy |
Bollinger Bands (100): | (2.08 - 3.44) | Sell |
Heron Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.05 while HRTX 8-day simple moving average is 1.98, which is a Buy signal.
- The stock price of HRTX is 2.05 while Heron Therapeutics 20-day SMA is 1.89, which makes it a Buy.
- Heron Therapeutics 50-day simple moving average is 2.22 while HRTX share price is 2.05, making it a Sell technically.
- HRTX stock price is 2.05 and Heron Therapeutics 200-day simple moving average is 2.60, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
21
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a Sell
The current Heron Therapeutics [HRTX] share price is $2.05. The Score for HRTX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
310.92M
Price in USD:
2.05
Share Volume:
2.14M
Heron Therapeutics 52-Week Range
52-Week High:
3.93
52-Week Low:
0.50
Sell
21
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?
The Heron Therapeutics stock price is 2.05 USD today. -
Will HRTX stock go up or go down?
Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Heron Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.05 while HRTX 8-day exponential moving average is 1.96, which is a Buy signal.
- The stock price of HRTX is 2.05 while Heron Therapeutics 20-day EMA is 1.96, which makes it a Buy.
- Heron Therapeutics 50-day exponential moving average is 2.20 while HRTX share price is 2.05, making it a Sell technically.
- HRTX stock price is 2.05 and Heron Therapeutics 200-day simple moving average is 2.45, creating a Sell signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
- HRTX Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Heron Therapeutics is a Sell
- Heron Therapeutics Relative Strength Index (RSI) is 53, which suggest Heron Therapeutics is overbought
- The Bollinger Bands (25) for Heron Therapeutics is (1.81 - 1.99), which suggest Heron Therapeutics is a Sell
- The Bollinger Bands (100) for Heron Therapeutics is (2.08 - 3.44), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.